136 related articles for article (PubMed ID: 2411995)
1. [Blood-brain barrier and the penetration of cytostatic drugs].
Unger C; Eibl H; von Heyden HW; Krisch B; Nagel GA
Klin Wochenschr; 1985 Jun; 63(12):565-71. PubMed ID: 2411995
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapeutic agent permeability to normal brain and delivery to avian sarcoma virus-induced brain tumors in the rodent: observations on problems of drug delivery.
Neuwelt EA; Barnett PA; Frenkel EP
Neurosurgery; 1984 Feb; 14(2):154-60. PubMed ID: 6200798
[TBL] [Abstract][Full Text] [Related]
3. Blood-brain barrier transport of butanol and water relative to N-isopropyl-p-iodoamphetamine as the internal reference.
Pardridge WM; Fierer G
J Cereb Blood Flow Metab; 1985 Jun; 5(2):275-81. PubMed ID: 3988826
[TBL] [Abstract][Full Text] [Related]
4. Transient and controllable opening of the blood-brain barrier to cytostatic and antibiotic agents by alkylglycerols in rats.
Erdlenbruch B; Jendrossek V; Eibl H; Lakomek M
Exp Brain Res; 2000 Dec; 135(3):417-22. PubMed ID: 11146820
[TBL] [Abstract][Full Text] [Related]
5. [The blood-brain barrier. II. Physiological data (conclusion)].
Lefauconnier JM; Hauw JJ
Rev Neurol (Paris); 1984; 140(2):89-109. PubMed ID: 6143382
[TBL] [Abstract][Full Text] [Related]
6. Intracarotid administration of short-chain alkylglycerols for increased delivery of methotrexate to the rat brain.
Erdlenbruch B; Schinkhof C; Kugler W; Heinemann DE; Herms J; Eibl H; Lakomek M
Br J Pharmacol; 2003 Jun; 139(4):685-94. PubMed ID: 12812991
[TBL] [Abstract][Full Text] [Related]
7. Transient blood-brain barrier passage of polar compounds at low pH.
Oldendorf WH; Stoller BE; Tishler TA; Williams JL; Oldendorf SZ
Am J Physiol; 1994 Dec; 267(6 Pt 2):H2229-36. PubMed ID: 7810722
[TBL] [Abstract][Full Text] [Related]
8. Permeability of the blood-brain barrier to mannitol in the rat following 2450 MHz microwave irradiation.
Preston E; Vavasour EJ; Assenheim HM
Brain Res; 1979 Sep; 174(1):109-17. PubMed ID: 487114
[TBL] [Abstract][Full Text] [Related]
9. Amphotericin B and the blood-brain barrier to methotrexate.
Barry DI; Paulson OB
Neurosurgery; 1982 Feb; 10(2):224-6. PubMed ID: 7070618
[TBL] [Abstract][Full Text] [Related]
10. Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability.
Levin VA
J Med Chem; 1980 Jun; 23(6):682-4. PubMed ID: 7392035
[TBL] [Abstract][Full Text] [Related]
11. Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier.
Pardridge WM; Triguero D; Yang J; Cancilla PA
J Pharmacol Exp Ther; 1990 May; 253(2):884-91. PubMed ID: 2338660
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption.
Park J; Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
J Control Release; 2017 Mar; 250():77-85. PubMed ID: 27742444
[TBL] [Abstract][Full Text] [Related]
13. Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone.
Pardridge WM; Mietus LJ
J Clin Invest; 1979 Jul; 64(1):145-54. PubMed ID: 447850
[TBL] [Abstract][Full Text] [Related]
14. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio.
Yang T; Martin P; Fogarty B; Brown A; Schurman K; Phipps R; Yin VP; Lockman P; Bai S
Pharm Res; 2015 Jun; 32(6):2003-14. PubMed ID: 25609010
[TBL] [Abstract][Full Text] [Related]
15. Comparison of radio-labeled butanol and iodoantipyrine as cerebral blood flow markers.
van Uitert RL; Sage JI; Levy DE; Duffy TE
Brain Res; 1981 Oct; 222(2):365-72. PubMed ID: 7284784
[TBL] [Abstract][Full Text] [Related]
16. Effects of gamma- and hydroxypropyl-gamma-cyclodextrins on the transport of doxorubicin across an in vitro model of blood-brain barrier.
Monnaert V; Betbeder D; Fenart L; Bricout H; Lenfant AM; Landry C; Cecchelli R; Monflier E; Tilloy S
J Pharmacol Exp Ther; 2004 Dec; 311(3):1115-20. PubMed ID: 15280439
[TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro evidence for nonrestricted transport of 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein tetraacetoxymethyl ester at the blood-brain barrier.
Hirohashi T; Terasaki T; Shigetoshi M; Sugiyama Y
J Pharmacol Exp Ther; 1997 Feb; 280(2):813-9. PubMed ID: 9023295
[TBL] [Abstract][Full Text] [Related]
18. Impermeability of the rat blood-brain barrier to exogenously administered gonadotropin-releasing hormone.
Verheugen C; Laufer LR; DeFazio JL; Pardridge WB; Lu JK; Judd HL
Neuroendocrinology; 1983 Feb; 36(2):102-4. PubMed ID: 6339975
[TBL] [Abstract][Full Text] [Related]
19. Modulating blood-brain barrier interactions of amino acid-based anticancer agents.
Killian DM; Gharat L; Chikhale PJ
Drug Deliv; 2000; 7(1):21-5. PubMed ID: 10895416
[TBL] [Abstract][Full Text] [Related]
20. New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy.
Rousselle C; Clair P; Lefauconnier JM; Kaczorek M; Scherrmann JM; Temsamani J
Mol Pharmacol; 2000 Apr; 57(4):679-86. PubMed ID: 10727512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
